Completed PHASE4 INTERVENTIONAL 2-arm NCT01837199

MTZ Plus AMX in the Treatment of Smokers and Non-smokers

Clinical and Microbiological Effects of Adjunctive Metronidazole Plus Amoxicillin in the Treatment of Generalized Chronic Periodontitis: Smokers Versus Non-Smokers.

Sponsor: University of Guarulhos

Conditions Chronic Periodontitis Smoking

Interventions Metronidazole plus Amoxicillin

Updated 5 times since 2017 Last updated: Apr 17, 2013 Started: Jul 31, 2011 Primary completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01837199, this PHASE4 trial focuses on Chronic Periodontitis and Smoking and remains completed. Sponsored by University of Guarulhos, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Guarulhos

Data source: University of Guarulhos

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guarulhos, Brazil